Cart
sales@molnova.com
Xanthyletin
CAS No. 553-19-5
Xanthyletin( —— )
Catalog No. M24541 CAS No. 553-19-5
Xanthyletin has anti-inflammatory, anti-tumor and anti-bacterial activities, it also inhibits symbiotic fungus cultivated by leaf-cutting ants.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 277 | In Stock |
|
| 5MG | 306 | In Stock |
|
| 10MG | 455 | In Stock |
|
| 25MG | 730 | In Stock |
|
| 50MG | 977 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXanthyletin
-
NoteResearch use only, not for human use.
-
Brief DescriptionXanthyletin has anti-inflammatory, anti-tumor and anti-bacterial activities, it also inhibits symbiotic fungus cultivated by leaf-cutting ants.
-
DescriptionXanthyletin has anti-inflammatory, anti-tumor and anti-bacterial activities, it also inhibits symbiotic fungus cultivated by leaf-cutting ants.
-
In VitroXanthyletin inhibits symbiotic fungus cultivated by leaf-cutting ants. Xanthyletin (25, 50, and 100 μg/mL) shows a total inhibition on the fungus.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
Recptorantifungal|ERK|MMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number553-19-5
-
Formula Weight228.24
-
Molecular FormulaC14H12O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (109.53 mM)
-
SMILESCC1(C)Oc2cc(OC(C=C3)=O)c3cc2C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.New benzo[c]phenanthridine and benzenoid derivatives, and other constituents from Zanthoxylum ailanthoides: Effects on neutrophil pro-inflammatory responses.Int J Mol Sci. 2013 Nov 13;14(11):22395-408.
molnova catalog
related products
-
1-Butanol
1-Butanol has an antioxidant effect, can decrease hyperglycemia. 1-Butanol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and the expression of inflammatory cytokines.
-
FR 180204
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
-
Patritumab
Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
